IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,691,000 | -37.4% | 300,000 | -48.8% | 0.34% | -48.3% |
| Q1 2023 | $9,085,122 | -12.6% | 585,759 | 0.0% | 0.66% | +1.9% |
| Q4 2022 | $10,397,222 | +218.1% | 585,759 | 0.0% | 0.65% | +156.3% |
| Q3 2022 | $3,269,000 | +43.1% | 585,759 | 0.0% | 0.25% | +16.7% |
| Q2 2022 | $2,284,000 | -29.2% | 585,759 | 0.0% | 0.22% | -21.5% |
| Q1 2022 | $3,228,000 | – | 585,759 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |